AUA 2018 Lower Urinary Tract Conditions – Nocturia

Viewing 1-20 of 34 articles

AUA 2018: A Catheter Insertion Force Assessment Tool: Design and Preclinical Results

AUA 2018: Risk Factors Associated with Fecal Incontinence in Patients with Overactive Bladder

AUA 2018: Concomitant Procedures Performed at the Time of Midurethral Sling Affect Post Operative Urinary Retention Rate

AUA 2018: Impact of Lifetime Obesity on Urinary Incontinence in the Women’s Health Initiative

AUA 2018: The Utility of Urodynamic Evaluation in Clinical Practice

AUA 2018: Elevated Post-Void Residual Volumes, Not Associated with Self-Reported Urinary Tract Infections: A Report From The Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN)

AUA 2018: Safety & Efficacy of the eCOIN™ Implantable Tibial Nerve Stimulation Device for Overactive Bladder Syndrome

AUA 2018: No Increased Risk of Clean Intermittent Catheterization with Onabotulinumtoxina Retreatment

AUA 2018: Onabotulinumtoxina Injection to the External Urethral Sphincter for Voiding Dysfunction in Females

AUA 2018: Bladder Neck Artificial Urinary Sphincter for Recurrent or Complex Primary Urodynamically Proven Stress and Mixed Urinary Incontinence

AUA 2018: Relationship Between Excess Visceral Fat Volume and Overactive Bladder

AUA 2018: Contemporary Review of Complications Associated with Autologous Rectus Fascia Pubovaginal Slings

AUA 2018: Efficacy and Safety of Add-on Mirabegron vs Placebo to Tamsulosin in Men with Overactive Bladder Symptoms MATCH Study

AUA 2018: Insomnia Induces Lower Urinary Tract Symptoms: The Natural History and Risk Factors for LUTS from the Nagahama Longitudinal Study

AUA 2018: Extended First Uninterrupted Sleep Period in Elderly Patients Following Treatment with AV002, an Emulsified Low Dose Vasopressin Analog for Nocturia

AUA 2018: The “Metabolic” Overactive Bladder Syndrome

AUA 2018: A Prospective Study to Evaluate Efficacy with the Nuro™ Percutaneous Tibial Neuromodulation System in Drug Naïve Patients with Overactive Bladder Syndrome

AUA 2018: Underactive Bladder: Evaluation and Management

AUA 2018: OAB - Therapeutic Algorithm for Third-Line Therapies: When I Use What, and Why?

AUA 2018: Association Between Overactive Bladder Severity and Bold fMRI Brain Activity

1
2

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.